Speaker Details

Matthew Hobbs

Director of Research, Prostate Cancer UK

Matthew was appointed Prostate Cancer UK’s Director of Research in June 2020, having joined the organisation in 2013 as Deputy Director of Research. He is responsible for developing and overseeing the charity’s ambitious research strategy, and making sure that only research with the best chance of making a difference for men is funded.
Prostate Cancer UK is the largest funder of non-commercial prostate cancer research in the UK, committing £10-12m annually to fund new research across all disease stages spanning the translational pathway from discovery to clinical trials. The charity has a major focus on reducing late diagnosis of the disease and Matthew played a lead role in developing and funding the charity’s TRANSFORM trial – a £42m investment to deliver the largest prostate cancer screening trial in over 20 years.

Matthew leads Prostate Cancer UK’s research team: ensuring that the charity is fully informed about prostate cancer research happening around the world, identifying and investing in areas of the highest strategic importance, and making funding decisions based on sector-leading processes that exceed AMRC best practice guidance.

Prior to his roles with Prostate Cancer UK Matthew was the Head of Research at Diabetes UK (2012-13), Senior Project Manager for the NIHR Manchester Biomedical Research Centre (2010-2012) and Knowledge Transfer Partner with Manchester Business School developing tools for the NHS to support commercial clinical trials (2009-2010). He has a PhD in Chemistry, and MChem in Chemistry with French, from the University of Liverpool.